EVALUATION OF CLONIDINE IN PROPHYLAXIS OF MIGRAINE: Double-blind Trial and Follow-up
- 19 February 1972
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 299 (7747), 403-407
- https://doi.org/10.1016/s0140-6736(72)90855-0
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- 2-(2.6-DICHLOROPHENYLAMINO)-2-IMIDAZOLINE HYDROCHLORIDE (ST 155 OR CATAPRESAN) AS A PROPHYLACTIC REMEDY AGAINST MIGRAINEActa Neurologica Scandinavica, 1971
- Treatment of Hypertension with ClonidineBMJ, 1970
- CLONIDINE FOR MIGRAINEThe Lancet, 1969
- A POSSIBLE PHARMACOLOGICAL APPROACH TO MIGRAINEThe Lancet, 1969
- CIRCULATORY EFFECTS AT REST AND EXERCISE OF CLONIDINE, AN IMIDAZOLINE DERIVATIVE WITH HYPOTENSIVE PROPERTIESThe Lancet, 1969
- Investigations into the mechanism of the hypotensive effect of 2-(2,6-dichlorphenylamino)-2-imidazoline-HClEuropean Journal of Pharmacology, 1967
- Centrally mediated decrease in sympathetic tone induced by 2(2,6-dichlorophenylamino)-2 imidazoline (S.T. 155, Catapresan)European Journal of Pharmacology, 1967
- Klinische und klinisch-experimentelle Untersuchungen mit einer neuen blutdrucksenkenden Substanz: DichlorphenylaminoimidazolinDeutsche Medizinische Wochenschrift (1946), 1966